The two new GLP-1 trials, called evoke and evoke+, included nearly 4,000 people with early-stage Alzheimers
These mediators cause airway smooth muscle contraction, sensitize nerve terminals, promote mucus hypersecretion, vasodilation, and plasma extravasation from microvessels
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress
Venous thrombosis in patients with giant cell arteritis: features and outcomes in a cohort study
In addition, the magnitude of the 1-year mortality reduction observed in GLP-1 RA userslarger than in randomized trialssuggests that residual confounding may persist, including confounding by indication/clinical channeling and a healthy-user effect, and that estimates may be comparator-dependent
And theres no need to wait for any patents to expire to sell off-brand options of GLP-1 meds